Mutations in the charged multivesicular body protein 2B (CHMP2B) gene are of particular interest due to their association with FTD, Amyotrophic lateral sclerosis (ALS), and early-onset AD. The gene discussed is CHMP2B; the disease is frontotemporal dementia.